Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

About Rozebalamin (generic name: mecobalamin, development code: E0302) ...

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Scientists at UC Davis in Northern California have made a major breakthrough that could have a significant positive impact on ...

Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.

A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...

The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.

Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...

The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...